Dr. David Berman - Director, Queen's Cancer Research Institute
- Evaluates novel biomarkers for therapeutics in Bladder and Prostate cancer
Dr. Charles Graham – Principal Investigator, CBG Division
- Investigates the metastatic behaviour and resistance to therapy in Bladder cancer
Dr. Madhuri Koti - Principal Investigator, CBG Division
- Investigates the role of anti-tumour immunity in therapeutic response for Prostate and Bladder cancer
Dr. Christopher Mueller - Principal Investigator, CBG Division
- Evaluates novel biomarkers for disease progression in Prostate cancer
Dr. Parvin Mousavi – Professor, Queen’s Computing
- Computer-aided diagnosis and interventions for cancer detection